Citation Impact
Citing Papers
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Antibiotic Use in Crohnʼs Disease
1997
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Microbial factors in inflammatory bowel disease
2002
Comparative Metabolic Capabilities and Inhibitory Profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17
2007
Sunlight and Vitamin D
2013 Standout
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
2015
Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac
2013
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease
2003
Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder
2012
Treatment of severe Crohn's disease using antimycobacterial triple therapy — approaching a cure?
2002
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Epidemiology and risk factors for IBD
2015 Standout
The complex microbiota of raw milk
2013 Standout
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
Crohn's disease
2016 Standout
Crohn’s disease and the mycobacterioses: A quarter century later. Causation or simple association?
2012
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Use of antibiotics in the treatment of inflammatory bowel disease
2006
Microfluidic organs-on-chips
2014 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease
2007
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Atomoxetine Modulates Right Inferior Frontal Activation During Inhibitory Control: A Pharmacological Functional Magnetic Resonance Imaging Study
2008
A meta-analysis of antimycobacterial therapy for Crohn's disease
2000
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Lack of Support for a Common Etiology in Johneʼs Disease of Animals and Crohnʼs Disease in Humans
1999
Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors
2008
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics
1997
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
DNA Microarray Technology in the Clinical Environment:The AmpliChip CYP450 Test for CYP2D6 and CYP2C19 Genotyping
2009
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Minocycline: far beyond an antibiotic
2013 Standout
Associations between anuran tadpoles and salinity in a landscape mosaic of wetlands impacted by secondary salinisation
2006
Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans
2007
P450-catalyzed asymmetric cyclopropanation of electron-deficient olefins under aerobic conditions
2014 StandoutNobel
Emerging threats and persistent conservation challenges for freshwater biodiversity
2018 Standout
Drug Resistance in Cancer: An Overview
2014 Standout
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
2011
Works of Amanda Long being referenced
Atomoxetine Pharmacokinetics in Children and Adolescents with Attention Deficit Hyperactivity Disorder
2003
Controlled trial of antimycobacterial therapy in Crohn's disease
1991
Disposition and Metabolic Fate of Atomoxetine Hydrochloride: The Role of CYP2D6 in Human Disposition and Metabolism
2003
Multivariate Analyses of the Influences of Water Chemistry and Habitat Parameters on the Abundances of Pond-Breeding Amphibians
2003
Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites
2003